Publications

Trends in linezolid susceptibility patterns: Report from the 2002 – 2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. by Anderegg TR, Sader HS, Fritsche TR, Ross JE and Jones RN published in Int. J. Antimicrob. Agents 2005; 26 (1): 13-21

Therapeutic options among broad-spectrum β-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. by Jones RN, Fritsche TR and Sader HS published in Diagn. Microbiol. Infect. Dis. 2005; 52 (2): 129-133

Re-evaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms. by Pottumarthy S, Deshpande LM, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 52 (2): 95-99

Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi. by Booker BM, Smith PF, Forrest A, Bullock J, Kelchlin P, Bhavnani SM, Jones RN and Ambrose PG published in Antimicrob. Agents Chemother. 2005; 49 (5): 1775-1781

Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. by Ross JE, Anderegg TR, Sader HS, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 52 (1): 53-58

Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panels. by Rhomberg PR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 52 (1): 67-69

Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms. by Jones, R.N., Sader, H.S., Fritsche, T.R. published in Diagn. Microbiol. Infect. Dis. 2005; 52 (1): 71-74

Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. by Stelling JM, Travers K, Jones RN, Turner PJ, O’Brien TF and Levy SB published in Emerg. Infect. Dis. 2005; 11 (6): 873-882

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multidrug resistant Pseudomonas aeruginosa and Acinetobacter spp. by Sader, H.S., Jones, R.N. published in Int. J. Antimicrob. Agents. 2005; 25 (5):380-384

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. by Streit, J.M., Steenbergen, J.N., Thorne, G.M., Alder, J., Jones, R.N. published in J. Antimicrob. Chemother. 2005; 55 (4): 574-578

Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels. by Ross JE, Sader HS, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (3): 219-221

Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002 – 2003): Contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. by Pottumarthy S, Fritsche TR, Sader HS, Stilwell MG and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (4): 282-289

Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan. by Bell JA, Turnidge JD, Inoue M, Kohno S, Hirakata Y, Ono Y and Jones RN published in J. Antimicrob. Chemother. 2005; 55 (2):276-278

Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance. by Fritsche, TR, Sader, HS, Cleeland, R, Jones, RN published in Antimicrob. Agents Chemother. 2005; 49 (4): 1468-147

Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content. by Rhomberg PR, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (3): 274-276

Quality control guidelines for testing Gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. by Jones RN, Anderegg TR and Swenson JM published in J. Clin. Microbiol. 2005; 43 (2): 925-927

Italian metallo-β-lactamases: A national problem? Report from the SENTRY Antimicrobial Surveillance Programme. by Toleman, M.A., Biedenbach, D., Bennett, D.M.C., Jones, R.N., Walsh, T.R published in J. Antimicrob. Chemother. 2005; 55 (1): 61-70

Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by Pottumarthy, S., Fritsche, T.R., Jones, R.N. published in Diagn. Microbiol. Infect. Dis. 2005; 51 (2): 147-150

Emerging epidemic of metallo-β-lactamase-mediated resistances. by Jones, R.N., Biedenbach, D.J., Sader, H.S., Fritsche, T.R., Toleman, M.A., Walsh, T.R. published in Diagn. Microbiol. Infect. Dis. 2005; 51 (2): 77-84

Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis). by Jones RN, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2005; 51 (2): 139-141

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American Medical Centres. by Gales AC, Sader HS, Jones RN published in Clin. Microbiol. Infect. 2005; 11 (2): 95-100

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. by Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (2):95-109

Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. by Bhavnani SM, Hammel JP, Jones RN and Ambrose PG published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 31-37

Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by DiPersio JR, Deshpande LM, Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 1-7

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: Validation report from the SENTRY Antimicrobial Surveillance Program. by Pottumarthy S, Fritsche TR, Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1):57-62

Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections. by Sader HS, Biedenbach DJ, Streit JM and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (1): 89-92

Dissemination and diversity of metallo-beta-lactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. by Sader HS, Castanhiera M, Mendes RE, Toleman M, Walsh TR, Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (1): 57-61

Activity of Tigecycline Tested against 3,498 Staphylococcus aureus (SA): An Assessment versus Community-Acquired (CA) ORSA, Lead author: Rhomberg PR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Emergence and Epidemic Clonality of Multi-Drug Resistant (MDR) S. pneumoniae (SPN; 1997 – 2003): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Johnson DM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods: Report from the College of American Pathologists (CAP) Microbiology Surveys Program (2001-2003), Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparison of Broth Microdilution (BMD) and Disk Diffusion (DD) Methods for Susceptibility Testing of Acinetobacter spp. (Acb) Collected Worldwide, Lead author: Swenson J, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Quality Control Guidelines for Broth Microdilution and Disk Diffusion Susceptibility Testing for Polymixin B and Colistin, Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparisons of Inter-Method Susceptibility Testing Accuracy for LBM415 (NVP PDF-713) Using 2,625 Recent Clinical Isolates, Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Campylobacter spp. Susceptibility Testing: A Multi Site Evaluation of Broth Microdilution Methods Compared to the Agar Dilution Method, Lead author: Knapp C, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Re-Evaluation of Enterobacteriaceae Regression/Scattergrams Using ESBL-Enriched Populations Tested against Eight Beta-Lactams, Lead author: Deshpande LM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

International Validation of Alternative Disk Diffusion Methods for Detecting mecA-Mediated Oxacillin (OX) Resistance (R) in Staphylococci: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparative Activity of Dalbavancin Tested against 7,771 Isolates from the USA and Europe (2003), Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of Doripenem (DOR) against Multi-Drug Resistant (MDR) Pseudomonas aeruginosa (PSA) and Streptococcus pneumoniae (SPN), Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of BAL9141 Tested against Staphylococcal Strains with Selected Resistance Patterns, Lead author: Deshpande LM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Activity of Tigecycline (TIG) Tested against Tetracycline-Resistant Enterobacteriaceae, Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Macrolide-Induction, Inoculum Effect and Kill-Curve Analysis of Telithromycin Tested against S. pneumoniae Strains with Characterized MLS_B Resistances, Lead author: Biedenbach DJ, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparative Antimicrobial Characterization of LBM415 (NVP PDF-713), a New Peptide Deformylase Inhibitor (PDI), Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of LBM 415 (NVP PDF-713) Tested against Neisseria meningitidis (NM) and N. gonorrhoeae (NG), Lead author: Rhomberg PR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity and Spectrum of PPI-0903 (TAK-599), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains, Lead author: Sader HS, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluation of PPI-0903 (TAK-599), a Novel Cephalosporin: Bactericidal Activity, Effects of Modifying Testing Parameters and Optimization of Disk Diffusion Tests, Lead author: Sader HS, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluating Antimicrobial (ABX) Use & Bacterial Resistance (R): Comparison of the Statistical Power Achieved for Different Regression Methods, Lead author: Bhavnani SM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluation of Patients with ESBL- and Non-ESBL Producing Enterobacteriaceae (ETB): Outcomes Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Bhavnani SM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

An Outbreak of Catalase-Negative Methicillin-Resistant Staphylococcus aureus, Lead author: Gales AC, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Validation of Etest for Antifungal Susceptibility Testing of 3 Agents using the FDA 510(k) Criteria for Antimicrobial Susceptibility Test (AST) Devices, Lead author: Bolmstrom A, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antifungal Susceptibility Results from a Worldwide Anidulafungin Surveillance Program (2002-2003), Lead author: Messer S, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC